What is Nova Tech EEG?
Nova Tech EEG operates as a critical infrastructure provider in the neuro-diagnostic space, specializing in the distribution of FDA 510K-cleared EEG amplifiers, most notably the Mitsar product line. Beyond hardware distribution, the firm distinguishes itself through its proprietary NTE Suite neurofeedback software, which facilitates advanced qEEG analysis and reporting. By integrating high-fidelity brain activity monitoring tools with expert-led accredited certification training, Nova Tech EEG serves a diverse clientele ranging from hospital systems to private neurological practices. Their business model effectively bridges the gap between complex technical instrumentation and practical clinical application, positioning them as a comprehensive partner for practitioners seeking to implement sophisticated neurofeedback protocols.
How much funding has Nova Tech EEG raised?
Nova Tech EEG has raised a total of $12K across 1 funding round:
Debt
$12K
Debt (2021): $12K with participation from PPP
Key Investors in Nova Tech EEG
PPP
Public-Private Partnership
What's next for Nova Tech EEG?
With the current Series A/B growth stage funding, Nova Tech EEG is well-positioned to scale its operational footprint and expand its educational outreach. The strategic deployment of this capital will likely focus on enhancing the NTE Suite software ecosystem and broadening the reach of their clinical training workshops. As the demand for non-invasive neurological monitoring continues to rise, the company is expected to prioritize the integration of new diagnostic features and the expansion of its distribution network. By maintaining a dual focus on technological innovation and professional development, Nova Tech EEG is poised to capture a larger share of the clinical neurology market, driving long-term value for both its clinical partners and stakeholders.
See full Nova Tech EEG company page
